新诊断2型糖尿病患者血浆中性粒细胞明胶酶相关脂笼蛋白与颈总动脉内膜中膜厚度的关系
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

教育部长江学者和创新团队发展计划资助项目(IRT1195),国家临床重点专科建设项目资助(卫办医政函[2011]873号)


The Relationship Between the Concentration of Plasma Lipocalin-2 and Common Carotid Artery Intima-medial Thickness in Newly Diagnosed Type 2 Diabetic Patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨新诊断2型糖尿病患者血浆中性粒细胞明胶酶相关脂笼蛋白(LCN2)浓度与颈总动脉内膜中膜厚度的关系。方法 共纳入166例年龄在35~70岁之间、病程在1年以内的新诊断2型糖尿病患者,同时选取同期的65例健康正常人作为对照。采用高分辨超声检测2型糖尿病患者颈总动脉内膜中膜厚度,用双抗体酶联免疫吸附法检测血浆LCN2浓度。结果 校正年龄、性别之后,2型糖尿病组的血浆LCN2浓度高于正常对照组(P<0.05)。将2型糖尿病组按照血浆LCN2浓度三分位分组,高浓度LCN2组颈总动脉内膜中膜厚度高于低浓度LCN2组(P0.026)。在校正多个因素后,血浆LCN2浓度与颈总动脉内膜中膜厚度呈正相关(r0.197,P0.007)。新诊断2型糖尿病患者的血浆LCN2浓度是其颈总动脉内膜中膜厚度增厚的相关因素之一。结论 新诊断2型糖尿病患者血浆LCN2浓度高于正常人,其血浆LCN2浓度与颈总动脉内膜中膜厚度呈正相关关系。血浆LCN2浓度上升可能是新诊断2型糖尿病患者颈总动脉内膜中膜厚度增厚的危险因素之一。

    Abstract:

    Aim To investigate the relationship between the concentration of plasma lipocalin-2 (LCN2) and common carotid artery intima-medial thickness (CCA-IMT) in newly diagnosed type 2 diabetic patients. Method 166 newly diagnosed type 2 diabetic patients (age 35~70, duration≤1 year) and 65 healthy people were recruited. CCA-IMT was detected by high-resolution ultrasonography, plasma concentration of LCN2 was measured by enzyme-linked immunosorbent assay. Results Adjusting for age and sex, type 2 diabetics’ plasma concentration of LCN2 was significantly higher than that in the healthy group (P<0.05). According to the three tilter of plasma concentration of LCN2, the highest concentration group’s CCA-IMT was significantly higher than that in the lowest concentration group (P0.026).

    参考文献
    相似文献
    引证文献
引用本文

李 兴,肖 扬,钟 慧,姚 岚,陈小燕,冯 琼,唐炜立,刘石平,周智广.新诊断2型糖尿病患者血浆中性粒细胞明胶酶相关脂笼蛋白与颈总动脉内膜中膜厚度的关系[J].中国动脉硬化杂志,2015,23(02):149~152.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2014-08-15
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: